首页|苓术散联合二甲双胍治疗脾虚湿阻证代谢综合征临床观察

苓术散联合二甲双胍治疗脾虚湿阻证代谢综合征临床观察

扫码查看
目的 探讨苓术散联合二甲双胍对脾虚湿阻证代谢综合征(MS)患者体格指标、生化指标及炎性因子水平的影响。方法 选取江苏省宜兴市中医医院 2020 年 10月至2023年3月收治的脾虚湿阻证MS患者88例,按随机数字表法分为对照组和研究组,各44例。两组患者均予二甲双胍联合常规综合治疗,研究组患者加用苓术散,均治疗 12 周。结果 治疗后,两组患者的体格指标(体质量、体质量指数、腰围、臀围)、生化指标(收缩压、舒张压、空腹血糖、餐后 2h血糖、空腹胰岛素、胰岛素抵抗指数、甘油三酯、总胆固醇、低密度脂蛋白胆固醇)均显著降低(P<0。05),且研究组均显著低于对照组(P<0。05);两组患者的炎性因子(C反应蛋白、肿瘤坏死因子-α、白细胞介素 6)水平均显著降低(P<0。05),且研究组均显著低于对照组(P<0。05);两组患者的高密度脂蛋白胆固醇水平均显著升高(P<0。05),且研究组显著高于对照组(P<0。05)。治疗期间,两组患者均未出现恶心呕吐、腹痛等不良反应。结论 苓术散联合二甲双胍治疗脾虚湿阻证MS,可降低患者的体质量、体质量指数,减少腰围、臀围,调节血压、糖代谢、脂代谢指标,减轻炎性反应,且安全性较好。
Clinical Observation of Lingzhu Powder Combined with Metformin in the Treatment of Metabolic Syndrome with Spleen Deficiency and Dampness Obstruction Syndrome
Objective To investigate the effect of Lingzhu Powder combined with metformin on physical indicators,biochemical indicators,and inflammatory factor levels in patients with metabolic syndrome(MS)with spleen deficiency and dampness obstruction syndrome.Methods A total of 88 patients with MS with spleen deficiency and dampness obstruction syndrome admitted to the Yixing Traditional Chinese Medicine Hospital from October 2020 to March 2023 were selected and divided into the control group and the study group by the random number table method,with 44 cases in each group.The patients in the two groups were treated with metformin combined with conventional comprehensive treatment,on this basis,the patients in the study group were treated with Lingzhu Powder.Both groups were treated for 12 weeks.Results After treatment,the physical indicators(body mass,body mass index,waist circumference,hip circumference),biochemical indicators(systolic blood pressure,diastolic blood pressure,fasting blood glucose,2-hour postprandial blood glucose,fasting insulin,insulin resistance index,triglycerides,total cholesterol,low-density lipoprotein cholesterol)in the two groups significantly decreased(P<0.05),and those in the study group were significantly lower than those in the control group(P<0.05).The levels of inflammatory factors(C-reactive protein,tumor necrosis factor-α,interleukin-6)in the two groups significantly decreased(P<0.05),and those in the study group were significantly lower than those in the control group(P<0.05).The level of high-density lipoprotein cholesterol in the two groups significantly increased(P<0.05),and that in the study group was significantly higher than that in the control group(P<0.05).During the treatment,no patients in the two groups had any adverse reactions such as nausea,vomiting,or abdominal pain.Conclusion Lingzhu Powder combined with metformin in the treatment of patients with MS with spleen deficiency and dampness obstruction syndrome can reduce the body mass,body mass index,waist circumference,and hip circumference,regulate blood pressure,glucose metabolism,and lipid metabolism indicators,alleviate inflammatory reactions,and it has high safety.

Lingzhu Powdermetforminmetabolic syndromespleen deficiency and dampness obstruction syndromephysical indicatorsbiochemical indicatorsinflammatory factors

吴汶轩、王瑶、戴欣珏、邓理、姚丽琴、叶丽芳

展开 >

南京中医药大学第一临床医学院,江苏 南京 210023

江苏省宜兴市中医医院,江苏 无锡 214200

南京中医药大学,江苏 南京 210023

苓术散 二甲双胍 代谢综合征 脾虚湿阻证 体格指标 生化指标 炎性因子

江苏省中医药科技发展计划

MS2021010

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(11)
  • 21